Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

Pregnancy Test Clinical Trial

— hyperPOC  

Official title:

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy After In-vitro Fertilization and Embryo Transfer.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03184519
• Other study ID #: 1701-VLC-011-EB
• Status: Completed
• Phase: N/A
• Start date: June 19, 2017
• Est. completion date: August 10, 2018

Study information

• Verified date: July 2020
• Source: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 156
• Est. completion date: August 10, 2018
• Est. primary completion date: August 10, 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion criteria:

• Written informed consent

• Patients undergoing their first or second IVF-ET cycle

• Age 18-45 years

• Use of Ovitrelle for final follicular maturation and luteinization

• Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation)

Exclusion criteria:

• Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother)

• Canceled IVF cycles

• GnRH agonist triggering cycles in the case of fresh ET.

Related Conditions & MeSH terms

• Pregnancy Test

Intervention

Diagnostic Test:
• Pregnancy test
Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.

Locations

Country	Name	City	State
Spain	IVI Valencia	Valencia

Sponsors (1)

Lead Sponsor	Collaborator
Instituto Valenciano de Infertilidad, IVI VALENCIA

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants With Early Detection of Pregnancy	Detection of Pregnancy on earlier dates (before day-11 after Embrio transfer)	One month